课题基金 / 基金详情

3D Genome Mapping in the Human Brain and its Implications for Schizophrenia

3D Genome Mapping in the Human Brain and its Implications for Schizophrenia
人脑 3D 基因组图谱及其对精神分裂症的影响
批准号:
9898467
负责人:
Prashanth Rajarajan
金额:
$5.05万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-05 至 2021-04-04

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
PROJECT SUMMARY The human genome has traditionally been studied as a linear entity, ignoring how three-dimensional looping interactions that bring together distal non-coding regulatory elements and proximal promoters may modulate gene expression. Even with innovations in chromosome conformation capture techniques, the 3D neuroepigenome remains largely underexplored. Exploration of cell-type-specific chromosomal conformations will advance insight into hitherto unknown roles of non-coding sequences in the neurobiology of psychiatric disorders such as schizophrenia. The basic mechanisms of these processes can be elucidated using a human induced pluripotent stem cell-based platform, where isogenic neural cell types can be inexhaustibly derived from one individual. In this proposal, we seek to explore how 3D chromatin interactions and topology change based on cell type given an identical genotypic background in normal human neural differentiation, from neural progenitor to either astrocyte or excitatory neuron. I hypothesize that identity-specific regulatory element- promoter loops will emerge that connect noncoding sequences to transcription start sites, thereby modulating gene expression. By overlaying known schizophrenia “risk loci,” many of which are in noncoding regions, on neuron-specific chromatin loops, I will attempt to find those loci that occur in sequences of the genome critical for loop formation. Finally, I hypothesize that by manipulating such candidate (i.e., risk-loci-bearing) loops with targeted CRISPR epigenetic editing, I will observe changes in gene expression. Findings from the proposed project will greatly advance knowledge in the field of how the 3D genome can quite literally contribute to the risk architecture of psychiatric disease, promoting the development of more effective diagnosis and treatment in the future.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/bs.pmbts.2017.11.022
发表时间: 2018
期刊: Progress in molecular biology and translational science
影响因子: --
作者: [Rajarajan P, Jiang Y, Kassim BS, Akbarian S]
通讯作者: Akbarian S
海外基金